SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · Real-Time Price · USD
2.400
+0.110 (4.80%)
Oct 7, 2025, 1:39 PM EDT - Market open
SAB Biotherapeutics Market Cap
SAB Biotherapeutics has a market cap or net worth of $24.99 million as of October 7, 2025. Its market cap has decreased by -1.19% in one year.
Market Cap
24.99M
Enterprise Value
24.55M
1-Year Change
-1.19%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since February 9, 2021, SAB Biotherapeutics's market cap has decreased from $130.75M to $24.99M, a decrease of -80.89%. That is a compound annual growth rate of -29.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 23.84M | -31.92% |
| Dec 31, 2024 | 35.02M | -44.79% |
| Dec 29, 2023 | 63.43M | 113.36% |
| Dec 30, 2022 | 29.73M | -91.24% |
| Dec 31, 2021 | 339.54M | 159.68% |
| Feb 9, 2021 | 130.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |